Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arrowhead Pharmaceuticals (ARWR) Return on Sales (2016 - 2025)

Historic Return on Sales for Arrowhead Pharmaceuticals (ARWR) over the last 16 years, with Q4 2025 value amounting to 0.11%.

  • Arrowhead Pharmaceuticals' Return on Sales rose 701900.0% to 0.11% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.21%, marking a year-over-year increase of 2600300.0%. This contributed to the annual value of 0.04% for FY2025, which is 1717300.0% up from last year.
  • As of Q4 2025, Arrowhead Pharmaceuticals' Return on Sales stood at 0.11%, which was up 701900.0% from 0.06% recorded in Q3 2025.
  • In the past 5 years, Arrowhead Pharmaceuticals' Return on Sales ranged from a high of 0.68% in Q1 2025 and a low of 171.7% during Q3 2024
  • Its 5-year average for Return on Sales is 17.54%, with a median of 2.26% in 2021.
  • In the last 5 years, Arrowhead Pharmaceuticals' Return on Sales tumbled by -1648000bps in 2024 and then surged by 1717600bps in 2025.
  • Over the past 5 years, Arrowhead Pharmaceuticals' Return on Sales (Quarter) stood at 2.29% in 2021, then soared by 71bps to 0.67% in 2022, then tumbled by -5603bps to 38.12% in 2023, then plummeted by -84bps to 70.09% in 2024, then skyrocketed by 100bps to 0.11% in 2025.
  • Its last three reported values are 0.11% in Q4 2025, 0.06% for Q3 2025, and 6.43% during Q2 2025.